(2023)
Inability to work following COVID-19 vaccination-a relevant aspect for future booster vaccinations.
Public Health 222,
186-195.
Publications
(2023)
Glass microneedles: A case sudy for regulatory approval using a quality by design approach.
Adv Mater 35(52),
e2305834.
(2023)
Virus variant-specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022.
Clin Microbiol Infect 29(2),
225-232.
(2023)
Determinants of Influenza A infection rate in post-COVID-19 era.
J Infect 87(4),
361-364.
(2023)
Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination.
Eur Respir J 61(1),
2201390.
(2023)
Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster.
Clin Microbiol Infect 29(4),
554-556.
(2023)
The relationship between mental health, sleep quality and the immunogenicity of COVID-19 vaccinations.
J Sleep Res ,
e13929.
(2023)
Differential network interactions between psychosocial factors, mental health, and health-related quality of life in women and men.
Sci Rep 13(1),
11642.
(2022)
Expert recommendations for prevention and management of Candida auris transmission.
Mycoses 65(6),
590-598.
(Review)
(2022)
Automated characterisation of neutrophil activation phenotypes in ex vivo human Candida blood infections.
Comput Struct Biotechnol J 20,
2297-2308.